Achievwin
★★  

US,
2024-06-07 17:42
(250 d 17:33 ago)

Posting: # 24024
Views: 2,596
 

 simulating dissolution data beyond observed lab data [Dissolution / BCS / IVIVC]

Can anyone point out me towards a step by step process for modeling and simulating dissolution data for prolonged duration (0-90 days) based on the lab data for a defined period (0-10 days)?

Can we use R for this exercise (any examples?)
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2024-06-07 18:30
(250 d 16:46 ago)

@ Achievwin
Posting: # 24025
Views: 2,039
 

 simulating dissolution data beyond observed lab data

Hi Achievwin,

❝ Can anyone point out me towards a step by step process for modeling and simulating dissolution data for prolonged duration (0-90 days) based on the lab data for a defined period (0-10 days)?

If your cumulative dissolution is visually flattening, yes. Otherwise, you are fishing in the dark. Can you post some data?

❝ Can we use R for this exercise [?]

Likely. It depends on the number of parameters of the function you will fit (e.g., monoexponential, Weibull…) and sampling time points you have. In any case, the confidence interval of the prediction beyond the observed data may become terribly wide, rendering this exercise a game of chance.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Rayhope
☆    

India,
2024-06-26 02:50
(232 d 08:25 ago)

@ Helmut
Posting: # 24038
Views: 1,535
 

 simulating dissolution data beyond observed lab data

❝ ❝ Can we use R for this exercise [?]

❝ Likely. It depends on the number of parameters of the function you will fit (e.g., monoexponential, Weibull…) and sampling time points you have. In any case, the confidence interval of the prediction beyond the observed data may become terribly wide, rendering this exercise a game of chance.


This is interesting case, Helmut, just a quick question about the fitting models mentioned, are these models accepted by regulatory agencies? whats your thoguht. Does agencies moved on from F2 calculations? Any experience on the same?
Regards.
dshah
★★  

India,
2024-06-10 11:10
(248 d 00:06 ago)

@ Achievwin
Posting: # 24027
Views: 1,907
 

 simulating dissolution data beyond observed lab data

Hi Achievwin,

I agree with Helmut's input.
Further- the assumptions used for extrapolation of modeling, the function/model used used for extrapolation, limitation of used model can be considered on a brief.
Generally, dissolution condition which can fasten the rate of release can be tried for e.g. increasing temperature, rpm, change over media, etc. so that it can be confirmed that the drug release is complete.

Regards,
Divyen
UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
30 visitors (0 registered, 30 guests [including 7 identified bots]).
Forum time: 10:16 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5